ABBV vs QRVO · P/E 81, rev $16.99B vs P/E 27, rev $3.68B
AbbVie Inc (ABBV) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the ABBV and QRVO stock pages for the full models.
Not investment advice.